LinkedIn IconTwitter Icon

28-29 November 2018, Berlin

About ICI Europe

With over 2000 checkpoint trials currently underway, it is more important than ever to benchmark your progress and learn exactly what it will take to realise success in this field.

Focused specifically on immune checkpoint modulators, the ICI Europe Summit is not just another broad immuno-oncology meeting. Rather than covering a random selection of immuno-oncology combinations, ICI Europe provides you with insights into how checkpoint combinations can impact every stage of the cancer immunity cycle, enhancing the long-term success of immuno-oncology drug development.

This meeting has been researched and developed with over 40 leading organizations in IO, and incorporates the perspectives of  Merck MSD, Innate Pharma, Immutep, EMD Serono and many others. Click here to take a look at the agenda, speaker line-up and workshop sessions to find out more.

Join the leaders of the immuno-oncology community in Berlin to seize on the wealth of opportunities to ensure that you: